Aurobindo, Hetero Reach Deals in Valsartan, Losartan Drugs MDL
April 30, 2024
DOCUMENTS
- Letter
CAMDEN, N.J. — Plaintiffs in the MDL involving allegedly contaminated valsartan- and losartan-containing drugs told a New Jersey federal judge that they have reached deals with Aurobindo Pharmaceuticals Ltd. and Hetero Pharmaceuticals Ltd. that will resolve all personal injury, economic loss, and medical monitoring claims.
In an April 25 letter to Judge Renee Marie Bumb of the U.S. District Court for the District of New Jersey, plaintiffs said an agreement in principle was made with Aurobindo and the parties are preparing settlement papers.
In addition, they plan on moving Judge Bumb for preliminary approval of a class settlement of …
FIRM NAMES
- Honik LLC
- Kanner & Whiteley LLC
- Mazie Slater Katz & Freeman LLC
- Nigh Goldenberg Raso & Vaughn PLLC
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel